Livzon Pharma releases Interim Report 2026 online, details shareholder communication arrangements

Bulletin Express08-21

Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 21 August 2026 that the English and Chinese versions of its Interim Report 2026 have been uploaded to both the company’s website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).

The board recommends shareholders review the electronic versions and notes the following key points:

• Distribution format: Registered shareholders who previously elected to receive printed materials will find a hard copy of the Interim Report 2026 enclosed with the notification. • Requesting printed copies: Shareholders experiencing difficulty with electronic access may obtain free hard copies of the current and future corporate communications by completing and returning the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid post or email (1513-ecom@vistra.com). • Email registration: Shareholders are responsible for providing and updating a valid email address. Without a functional address on file, shareholders will receive future notices and actionable corporate communications in printed form only. • Registrar and contact details: All correspondence should be directed to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Telephone enquiries can be made on (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).

The communication was issued under the authority of the board and signed by Company Secretary Liu Ning.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1152801251?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152801251","market":"us","top_or_hot":-1,"title":"Livzon Pharma releases Interim Report 2026 online, details shareholder communication arrangements","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 21 August 2026 that the English and Chinese versions of its Interim Report 2026 have been uploaded to both the company’s website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).</p>\n<p>The board recommends shareholders review the electronic versions and notes the following key points:</p>\n<p>• Distribution format: Registered shareholders who previously elected to receive printed materials will find a hard copy of the Interim Report 2026 enclosed with the notification.  \n• Requesting printed copies: Shareholders experiencing difficulty with electronic access may obtain free hard copies of the current and future corporate communications by completing and returning the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid post or email (1513-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and updating a valid email address. Without a functional address on file, shareholders will receive future notices and actionable corporate communications in printed form only.  \n• Registrar and contact details: All correspondence should be directed to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Telephone enquiries can be made on (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).</p>\n<p>The communication was issued under the authority of the board and signed by Company Secretary Liu Ning.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma releases Interim Report 2026 online, details shareholder communication arrangements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma releases Interim Report 2026 online, details shareholder communication arrangements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-21 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 21 August 2026 that the English and Chinese versions of its Interim Report 2026 have been uploaded to both the company’s website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).</p>\n<p>The board recommends shareholders review the electronic versions and notes the following key points:</p>\n<p>• Distribution format: Registered shareholders who previously elected to receive printed materials will find a hard copy of the Interim Report 2026 enclosed with the notification.  \n• Requesting printed copies: Shareholders experiencing difficulty with electronic access may obtain free hard copies of the current and future corporate communications by completing and returning the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid post or email (1513-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and updating a valid email address. Without a functional address on file, shareholders will receive future notices and actionable corporate communications in printed form only.  \n• Registrar and contact details: All correspondence should be directed to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Telephone enquiries can be made on (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).</p>\n<p>The communication was issued under the authority of the board and signed by Company Secretary Liu Ning.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1152801251","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152801251","pubTimestamp":1787306785,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 21 August 2026 that the English and Chinese versions of its Interim Report 2026 have been uploaded to both the company’s website...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药在线发布2026年中期报告，详细介绍股东沟通安排","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 21 August 2026 that the English and Chinese versions of its Interim Report 2026 have been uploaded to both the company’s website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).\nThe board recommends shareholders review the electronic versions and notes the following key points:\n• Distribution format: Registered shareholders who previously elected to receive printed materials will find a hard copy of the Interim Report 2026 enclosed with the notification.  \n• Requesting printed copies: Shareholders experiencing difficulty with electronic access may obtain free hard copies of the current and future corporate communications by completing and returning the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via prepaid post or email (1513-ecom@vistra.com).  \n• Email registration: Shareholders are responsible for providing and updating a valid email address. Without a functional address on file, shareholders will receive future notices and actionable corporate communications in printed form only.  \n• Registrar and contact details: All correspondence should be directed to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Telephone enquiries can be made on (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).\nThe communication was issued under the authority of the board and signed by Company Secretary Liu Ning.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1152801251","isCrawlerRequest":true}